Aims and Scope

ExRNA (ISSN 2398-0060) is a peer-reviewed, open access journal that provides a platform for innovative research in the field of extracellular RNA. The journal covers a wide variety of RNAs in the extracellular environment, including miRNAs, siRNAs, piRNAs, lncRNAs and circRNAs.

This journal aims to investigate the biological functions of extracellular RNAs, discover the fundamental principles about the mechanisms of extracellular RNA generation, uptake and transport and explore the potential for using extracellular RNAs in the clinic as therapeutic molecules or disease biomarkers.

ExRNA encompasses all topics related to the biology of extracellular RNAs, including, but not limited to:

• Functional analysis of the biodistribution, structure and biological activity of extracellular RNAs
• Mechanistic studies on the production, transport, uptake, processing, modulation and modification of extracellular RNAs
• Translational studies to identify biomarkers and develop new tools, therapies and technologies to measure extracellular RNAs.

Previously published by BMC (https://exrna.biomedcentral.com) from February 1st, 2019 to December 31st, 2020, ExRNA starts to be published by AME Publishing Company from January 1st, 2021.

ExRNA is affiliated with

• Nanjing University
• Nanjing University Institute of Artificial Intelligence Biomedicine

Indexing

ExRNA is indexed and covered by

• Scopus

Information for Authors

ExRNA follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines.

Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.

Submission Turnaround Time

• In-house review: 1-3 weeks
• External peer review: 1-3 months
• Publication Ahead of Print: within 1 month after being accepted
• Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.

Open Access Statement

ExRNA is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

Free access and usage

Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:

• this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
• the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
• no derivatives including remix, transform, or build upon the material was allowed for distribution.

The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright

For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to AME Publishing Company, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.

For any inquiry/special circumstance on the copyright, commercial usage or adaptation of ExRNA articles, please contact: permissions@amegroups.com

For reprint order, please contact: sales@amegroups.com

Editorial Office

Email: exrna@amepc.org

Publisher Information

ExRNA is published by AME Publishing Company.
Addresses:
Hong Kong branch office: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Singapore branch office: Pico Creative Centre, 20 Kallang Ave #03-08, 339411 Singapore, Singapore.

Updated on July 19, 2024